None
Conditions
Interventions
Female reproductive hormone observation group:None
Sponsors
Guangdong Second Provincial General Hospital (Guangdong Provincial Emergency Hospital)
Eligibility
Sex/Gender
Female
Age
20 Years to 55 Years
Inclusion criteria
Inclusion criteria: 1) Venous whole blood samples with residual volume sufficient for testing that are permitted for secondary research use under broad informed consent; 2) Samples accompanied by the minimum necessary clinical information required for this study (e.g., age, menstrual cycle phase, pregnancy status, and relevant hormone test records); 3) Female participants aged 20–55 years; 4) Samples from individuals who have previously undergone fertility-related hormone testing at our hospital, including AMH, PRL, E2, PROG, and total ß-HCG.
Exclusion criteria
Exclusion criteria: 1) Samples with severe hemolysis, clotting, lipemia, or other quality issues that render them unsuitable for hormone testing; 2) Samples explicitly labeled in the original electronic medical record or laboratory information system as prohibited from secondary use; 3) Samples deemed by the ethics committee or designated by administrative authorities as not permitted for use in this study; 4) Samples with insufficient residual volume to complete all test items.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anti-Müllerian hormone;Prolactin;Estriol;Progesterone;Total ß-human chorionic gonadotropin; | — |
Countries
China
Contacts
Public ContactXuan Zhou
Guangdong Second Provincial General Hospital
Outcome results
None listed